Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FL5SX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,943
Award facts
- Contract value 100% obligated
- $6,943.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $6,943.10 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Nexplanon 68 mg implants, with an ultimate completion date of May 29, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA's SPE2DB program, a comprehensive pharmaceutical supply agreement valued at $499,999,999 and valid through November 2026.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, specializing in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The company's extensive contract portfolio with the DLA demonstrates its established capability in delivering specialized pharmaceutical products, including contraceptive devices, oncology treatments, and other prescription medications. This delivery order for Nexplanon implants—a contraceptive device—represents a routine issuance under the existing IDC framework, enabling the Defense Logistics Agency to efficiently procure pharmaceutical products in support of military health facility operations.
Quick answers
Who was awarded contract SPE2DB25FL5SX?
SPE2DB25FL5SX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 7, 2025.
How much is contract SPE2DB25FL5SX worth?
The government has obligated $6,943 on SPE2DB25FL5SX.
Is contract SPE2DB25FL5SX an order under another contract?
Yes. SPE2DB25FL5SX is a delivery order under SPE2DB22D9209, an indefinite delivery contract.
Was contract SPE2DB25FL5SX competed?
The extent of competition for SPE2DB25FL5SX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award